The ongoing trade conflict and increasing economic concerns weigh heavily on earnings expectations. Yet, forecasts for the US ...

Fears are growing in the EU that sanctions against Russia may expire in July. Options for frozen foreign exchange reserves ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

Philip Morris shares have risen by more than 50% in the past twelve months – the transformation is going well. In an ...

Following the recent near-financial crash, calls to exclude US government bonds from banks’ capital ratios are growing louder ...

The US insurer Willis Towers Watson is an alternative to defensive US stocks from the food industry. The business is ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

After Accelleron, ABB is preparing its next billion dollar IPO. The new CEO is making his mark and delivers good results.

Six investment professionals tell our readers how to navigate in view of new US trade barriers. Today Philipp Lienhardt, Head ...

The violent market movements are a stress test for stocks rated as «immune to fluctuations». Some withstand the turbulences ...

Tough times for Stadler: shares at a record low, not a single buy recommendation, return on capital has fallen below the cost ...

In the USA and the UK, government bonds are coming under pressure and interest rates have risen. This is apparently due to ...